Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 253

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part II, Item 6
Chunk 253
---
 authorized.

 CORCEPT THERAPEUTICS INCORPORATED  Date: November 4, 2025/s/ Joseph K. Belanoff Joseph K. Belanoff, M.D.Chief Executive Officer  Date: November 4, 2025/s/Atabak Mokari Atabak Mokari Chief Financial OfficerDate:November 4, 2025/s/Joseph D. LyonJoseph D. LyonChief Accounting & Technology Officer

45